Amazon Sinks on Lower Guidance, Pinterest Up on Beat By Investing.com

After-Hours Stock Movers:

Amazon (AMZN) 14% LOWER; reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $127.1 billion versus the consensus estimate of $127.76 billion. Amazon sees Q4 2022 revenue of $140-148 billion, versus the consensus of $155.1 billion.

Edwards Lifesciences (EW) 11% LOWER; reported Q3 EPS of $0.61, $0.01 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.33 billion. Edwards Lifesciences sees FY2022 EPS of $2.40-$2.50, versus the consensus of $2.52.

Pinterest (PINS) 10% HIGHER; reported Q3 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $685 million versus the consensus estimate of $665.54 million.

L3Harris Technologies (LHX) 8% LOWER; reported Q3 EPS of $3.26, $0.15 worse than the analyst estimate of $3.41. Revenue for the quarter came in at $4.25 billion versus the consensus estimate of $4.41 billion. L3Harris Technologies sees FY2022 EPS of $12.75-$13.00, versus the consensus of $13.48. L3Harris Technologies sees FY2022 revenue of $16.8 million, versus the consensus of $17.39 million.

DexCom (DXCM) 7% HIGHER; reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74 million. DexCom sees Q4 2022 revenue of $2.88-2.91 billion, versus the consensus of $2.89 billion.

Deckers Brands (DECK) 6% LOWER; reported Q2 EPS of $3.80, $0.17 better than the analyst estimate of $3.63. Revenue for the quarter came in at $876 million versus the consensus estimate of $804.64 million. Deckers Brands sees FY2023 EPS of $17.50-$18.35, versus the consensus of $18.12.

Vertex Pharma (VRTX) 5% HIGHER; reported Q3 EPS of $4.01, $0.39 better than the analyst estimate of $3.62. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.22 billion. Vertex Pharma sees FY2022 revenue of $8.8-8.9 billion, versus the prior of $8.6-$8.8 billion and the consensus of $8.77 billion.

Gilead Sciences (GILD) 4% HIGHER; reported Q3 EPS of $1.90, $0.38 better than the analyst estimate of $1.52. Revenue for the quarter came in at $7 billion versus the consensus estimate of $6.13 billion.

Intel (INTC) 4% HIGHER; reported Q3 EPS of $0.59, $0.25 better than the analyst estimate of $0.34. Revenue for the quarter came in at $15.3 billion versus the consensus estimate of $15.43 billion. Intel sees Q4 2022 EPS of $0.20, versus the consensus of $0.60. Intel sees Q4 2022 revenue of $14-15 billion, versus the consensus of $16.3 billion

T-Mobile (TMUS) 3% HIGHER; reported Q3 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $19.48 billion versus the consensus estimate of $20.02 billion.

Apple (AAPL) 1% LOWER; reported Q4 EPS of $1.29, $0.03 better than the analyst estimate of $1.26. Revenue for the quarter came in at $90.1 billion versus the consensus estimate of $88.76 billion.